Sidley Healthcare Investment Conference 2026

As dealmaking and investment continue to shape the future of life sciences and healthcare, Sidley will convene senior leaders from pharma, biotech, healthcare, private equity, and venture capital to explore the forces defining the year ahead.

Join Sidley and industry decision-makers from around the world, including from Agomab, Astellas Pharma, AstraZeneca, AviadoBio, Caidya, Eurazeo Capital, Flagship Pioneering, GSK, Harbinger Health, J.P. Morgan, Labcorp, LetterOne Health, Monograph Capital and Sanofi for this one-day, in-person program in London. Virtual attendance is available for those joining from outside the UK.

Expect a day of sharp insights, dynamic discussion, and valuable networking as we explore how the continued convergence of innovation and capital is driving positive patient outcomes and investment returns.

Panels will include:

• Go West? European Biotech Innovation: U.S. Exits
• Healthcare M&A and Buyouts: State of the Market
• The AI Imperative: Reshaping Drug Development and Investment
• The Rise of China: A Partner, Not a Rival

View the Sidley Healthcare Investment Conference 2025 highlights.